{"DataElement":{"publicId":"4287131","version":"1","preferredName":"Immune System Process Laboratory Procedure Performed Type","preferredDefinition":"A description of the immune system process laboratory test.","longName":"4286091v1.0:4286074v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"4286091","version":"1","preferredName":"Immune System Process Laboratory Procedure Performed","preferredDefinition":"Any multicellular process of immune cells effecting or involved with the immune response or immune maintenance. (NCI)_Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.","longName":"4286089v1.0:2241241v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"4286089","version":"1","preferredName":"Immune System Process Laboratory Procedure","preferredDefinition":"Any multicellular process of immune cells effecting or involved with the immune response or immune maintenance. (NCI):Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C17937:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune System Process","conceptCode":"C17937","definition":"Any multicellular process of immune cells effecting or involved with the immune response or immune maintenance. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-88E5-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-88F3-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"KUMMEROA","dateModified":"2021-01-06","changeDescription":". 2021-1-6 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4286074","version":"1","preferredName":"Immune System Process Type","preferredDefinition":"Any multicellular process of immune cells effecting or involved with the immune response or immune maintenance. (NCI)_Something distinguishable as an identifiable class based on common qualities.","longName":"4286074v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Granulocyte chemotaxis","valueDescription":"Chemotactic Process Granulocyte","ValueMeaning":{"publicId":"4286075","version":"1","preferredName":"Chemotactic Process Granulocyte","longName":"4286075","preferredDefinition":"The characteristic directional movement or orientation of an organism or cell along a chemical concentration gradient either toward or away from the chemical stimulus.: A leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotactic Process","conceptCode":"C16422","definition":"The characteristic directional movement or orientation of an organism or cell along a chemical concentration gradient either toward or away from the chemical stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Granulocyte","conceptCode":"C12530","definition":"A type of leukocyte with a multilobed nucleus and cytoplasmic granules. The unique morphology of the nucleus has led to their also being known as polymorphonuclear leukocytes (PMLs or PMNs). Granulocytes are subdivided according to the staining properties of their granules into eosinophils (red with acidic dye), basophils (blue with basic dye), and neutrophils (not amenable to staining with either acidic or basic dyes).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-8804-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8482CB3-881D-D115-E040-BB89AD437D77","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","deletedIndicator":"No"},{"value":"Cytotoxic T-cell activity","valueDescription":"Cytotoxic Activity T-Lymphocyte","ValueMeaning":{"publicId":"4286076","version":"1","preferredName":"Cytotoxic Activity T-Lymphocyte","longName":"4286076","preferredDefinition":"Having the ability to kill cells.: An active process; excludes processes and mechanisms which fulfill biological functions.: A type of immune cell that can attack foreign cells, cancer cells, and cells infected with a virus. T lymphocytes can also help control immune responses. A T lymphocyte is a type of white blood cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytotoxic","conceptCode":"C37893","definition":"Having the ability to kill cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Activity","conceptCode":"C43431","definition":"An active process; excludes processes and mechanisms which fulfill biological functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T-Lymphocyte","conceptCode":"C12476","definition":"A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-882B-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8482CB3-8844-D115-E040-BB89AD437D77","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","deletedIndicator":"No"},{"value":"Degranulation of cytolytic lymphocytes","valueDescription":"Mast Cell Degranulation Cytolytic Process Lymphocyte","ValueMeaning":{"publicId":"4286079","version":"1","preferredName":"Mast Cell Degranulation Cytolytic Process Lymphocyte","longName":"4286079","preferredDefinition":"The regulated exocytosis of secretory granules by a mast cell.: Any cell death process resulting from rupture of cell membranes and loss of cytoplasm.: A type of immune cell that is made in the bone marrow and is found in the blood and in lymph tissue. The two main types of lymphocytes are B lymphocytes and T lymphocytes. B lymphocytes make antibodies, and T lymphocytes help kill tumor cells and help control immune responses. A lymphocyte is a type of white blood cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mast Cell Degranulation","conceptCode":"C114629","definition":"The regulated exocytosis of secretory granules by a mast cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cytolytic Process","conceptCode":"C61553","definition":"Any cell death process resulting from rupture of cell membranes and loss of cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphocyte","conceptCode":"C12535","definition":"White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each); those with characteristics of neither major class are called null cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-8860-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8482CB3-8879-D115-E040-BB89AD437D77","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","deletedIndicator":"No"},{"value":"Platelet aggregation","valueDescription":"Platelet Aggregation Process","ValueMeaning":{"publicId":"4286080","version":"1","preferredName":"Platelet Aggregation Process","longName":"4286080","preferredDefinition":"Any cell adhesion process that involves the association of platelets via adhesion molecules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platelet Aggregation Process","conceptCode":"C16999","definition":"Any cell adhesion process that involves the association of platelets via adhesion molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-8883-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8482CB3-889C-D115-E040-BB89AD437D77","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","deletedIndicator":"No"},{"value":"Phytohemagglutinin","valueDescription":"Phytohemagglutinin","ValueMeaning":{"publicId":"4119864","version":"1","preferredName":"Phytohemagglutinin","longName":"4119864","preferredDefinition":"A class of lectins, found in beans, with hemagglutination properties. Phytohemagglutinin binds to complex oligosaccharides containing galactose, N-acetylglucosamine and mannose, causing agglutination of most mammalian red blood cell types. It induces mitosis and affects cell membrane permeability, thereby facilitating protein transport.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phytohemagglutinin","conceptCode":"C88791","definition":"A class of lectins, found in beans, with hemagglutination properties. Phytohemagglutinin binds to complex oligosaccharides containing galactose, N-acetylglucosamine and mannose, causing agglutination of most mammalian red blood cell types. It induces mitosis and affects cell membrane permeability, thereby facilitating protein transport.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F12137BF-B8AC-6257-E040-BB89AD434C83","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-29","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8482CB3-88B0-D115-E040-BB89AD437D77","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","deletedIndicator":"No"},{"value":"Natural killer cell activity","valueDescription":"Activity Natural Killer Cell","ValueMeaning":{"publicId":"4286082","version":"1","preferredName":"Activity Natural Killer Cell","longName":"4286082","preferredDefinition":"An active process; excludes processes and mechanisms which fulfill biological functions.: A type of immune cell that has granules (small particles) with enzymes that can kill tumor cells or cells infected with a virus. A natural killer cell is a type of white blood cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activity","conceptCode":"C43431","definition":"An active process; excludes processes and mechanisms which fulfill biological functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Natural Killer Cell","conceptCode":"C12536","definition":"Natural killer cells are cells that resemble large granular lymphocytes.  They do not express markers of either T or B cell lineage. They are positive for CD16, CD56, and CD 94.  These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody and killing may occur without previous sensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-88BF-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8482CB3-88D8-D115-E040-BB89AD437D77","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4286073","version":"1","preferredName":"Immune System Process Type","preferredDefinition":"Any multicellular process of immune cells effecting or involved with the immune response or immune maintenance. (NCI):Something distinguishable as an identifiable class based on common qualities.","longName":"C17937:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune System Process","conceptCode":"C17937","definition":"Any multicellular process of immune cells effecting or involved with the immune response or immune maintenance. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-87DA-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8482CB3-87EB-D115-E040-BB89AD437D77","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"KUMMEROA","dateModified":"2021-01-06","changeDescription":". 2021-1-6 ak Ok to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What type of immune system pr","type":"Preferred Question Text","description":"What type of immune system process laboratory procedure was performed?","url":null,"context":"NHLBI"},{"name":"What were the immunologic function types?","type":"Alternate Question Text","description":"What were the immunologic function types?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F85A9354-DF05-8A88-E040-BB89AD432EFA","latestVersionIndicator":"Yes","beginDate":"2014-05-01","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-01","modifiedBy":"KUMMEROA","dateModified":"2021-01-06","changeDescription":". 2021-1-6 ak OK to release per WZ. System generated def displayed as alt def. AK 10/26/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}